Net profit of Orchid Pharma declined 29.39% to Rs 20.78 crore in the quarter ended December 2024 as against Rs 29.43 crore during the previous quarter ended December 2023. Sales declined 1.47% to Rs 217.34 crore in the quarter ended December 2024 as against Rs 220.59 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 217.34 | 220.59 | -1 |
| OPM % | 12.13 | 16.04 | - |
| PBDT | 31.06 | 39.46 | -21 |
| PBT | 22.45 | 30.19 | -26 |
| NP | 20.78 | 29.43 | -29 |